496 Toxicity of an Fc engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable anti-tumor immunity in patients

• Mark Robson,
• Christopher Klebanoff,
• David Knorr,
• Jeffrey Ravetch,
• Gabriela D’Andrea,
• Linda Vahdat

Affiliations

Mark Robson

15 Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA

Christopher Klebanoff

2MSKCC, New York, NY, USA

David Knorr

1Rockefeller University, New York, USA

Jeffrey Ravetch

1Rockefeller University, New York, USA

Gabriela D’Andrea

2MSKCC, New York, NY, USA

Linda Vahdat

2MSKCC, New York, NY, USA